Aditya Infotech IPO Day 3: Check GMP, Subscription Status & Key Highlights
The ₹1300 crore Aditya Infotech IPO opened on July 29, 2025, and is scheduled to close today, 31 July 2025. The IPO received a total subscription of 6.87x till the end of Day 2.
Aditya Infotech IPO: Issue Details
Issue Size: Aditya Infotech IPO is a book-building issue of ₹1,300 crores, consisting of a fresh issue of ₹500 crores and an offer for sale of ₹800 crores.
Price Band: The company has set the price band between ₹640 and ₹675 per share.
Book-running lead managers: ICICI Securities Limited and IIFL Capital Services Limited
Registrar: MUFG Intime India Private Limited (Link Intime).
Listing: The shares are proposed to be listed on the NSE and the BSE on August 5.
Aditya Infotech IPO Day 3: Subscription Details
[31-July-2025 5:00:00 PM]
|
Investor Category |
Subscription (Times) |
|
Qualified Institutional Buyers (QIBs) |
133.21 |
|
Non-Institutional Investors |
71.99 |
|
Retail Individual Investors (RIIs) |
50.84 |
|
Employees |
8.50 |
|
Total |
100.68 |
Also Read : Aditya Infotech IPO Day 1: Subscription Status , Aditya Infotech IPO Day 2: Subscription Status
Utilisation of IPO Proceeds
The company aims to use the net proceeds from the fresh issue towards the following objectives.
- Repay/pre-pay outstanding borrowings
- General corporate purposes
Aditya Infotech IPO GMP Details
As of 31st July 2025, Aditya Infotech IPO's GMP stood at ₹285. The estimated listing price is ₹960, i.e., a 42.22% gain per share over the upper price band.
Source: Business Standard Report dated 31 July 2025
|
Disclaimer: The GMP (Grey Market Premium) price is an unauthenticated market related news and has no discernible basis. The same quoted above is as per news appeared in the media report and is for information purposes only. The investor shall do their own study/research before using the same for taking any decision to invest. We neither engage in, trade, or deal in the grey market nor we recommend or endorse trading in the grey market. |
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here